Medivir Receives The International Diamond Prize For Excellence In Quality

 Medivir AB (Nasdaq Stockholm: MVIR) today announces that the company has been awarded the International Diamond Prize for Excellence in Quality 2019. The Prize, run by the European Society for Quality Research (ESQR), recognizes the companies, public administrations and organizations, with superior development efforts and overall excellence, which are most committed to economic progress, both for themselves and their communities as a whole. The prize was received in Vienna on behalf of Medivir by Fredrik Öberg, CSO. Fredrik Öberg also gave a presentation of one of Medivir’s focus projects, MIV-818 for the treatment of liver cancer.-PR Newswire